http://ADPHARMA.NET
ADPHARMACEUTICALS1 5847dbd200671109b8397d6c False 298 20
OK
background image not found
Found results for
'single tablet'
Valif 20 mg (Vardenafil 20 mg) INR   0 INR  0
-NaN%

Valif 20 mg (Vardenafil 20 mg)

Valif 20 mg Tablet is used in the treatment of erectile dysfunction. Valif 20 mg Tablet is a phosphodiesterase (PDE-5) inhibitor. It works in erectile dysfunction by increasing blood flow to the penis by relaxing the muscles in penile blood vessels. It helps to get an erection only if the person is sexually stimulated. Use Levitra as directed by your doctor. Take Valif by mouth with or without food. Take Valif about 1 hour before sexual activity. Do not take Valif more often than once daily, or as directed by your doctor. Check with your doctor before you eat grapefruit or drink grapefruit juice while you use Valif. If you miss a dose of Valif and you still intend to engage in sexual activity, take it as soon as you remember. Continue to take it as directed by your doctor.

INR 0 INR 0

Availability:True

Pay mode:COD only

view details
Pirfenex (Pirfenidone) INR   0 INR  0
-NaN%

Pirfenex (Pirfenidone)

Pirfenex (Pirfenidone) is an anti-fibrotic medicine indicated for the treatment of the lung disease IPF (idiopathic pulmonary fibrosis). It is believed to work by decreasing fibroblast growth and slowing down disease progression. Uses Pirfenex (Pirfenidone) is an anti-fibrotic medicine indicated for the treatment of the lung disease IPF (idiopathic pulmonary fibrosis). It is believed to work by decreasing fibroblast growth and slowing down disease progression. IPF is a progressive disease in which the formation of scar tissue occurs in the lungs. This scar tissue gets thicker as the disease progresses, which causes stiff lungs. As a result of this, lung function is reduced and it is more difficult for oxygen to get from the lungs to the blood and vital organs. Breathing difficulties could also occur. This medicine may affect TGF (transmforming growth factor) and TNF (tumor necrosis factor) production, which can result in reduced inflammation and disruption of fibrosis. Although treatment will not cure the condition, it is used to help slow down the advancement of the disease. Dosage and Administration Pirfenex (Pirfenidone) comes in the form of 200mg strength tablets for oral administration. Patients are often told to take the medicine alongside food, so as to reduce the occurrence of vertigo or sickness. Physicians may direct patients to take it 3 times per day, however changes to the dosage schedule may be ordered by the physician, especially during the first 15 days after treatment commences. Regular medical appointments will be required so that your physician can monitor your progress and to ensure that it is not causing any harmful side effects to the liver. Make sure that you attend every scheduled check-up, and ensure that you comply with all instructions provided by the physician. Side effects Treatment of IPF or any other conditions with Pirfenex (Pirfenidone) may cause side effects. Report all reactions to your physician. Possible side effects include: * Weight loss * Decrease in appetite * Vertigo and headaches * Soreness occurring in the joints * Skin which is sensitive to sunburn Immediately consult your physician or attend the hospital straight away if you suffer from continued vomiting, dark discoloration of urine, persistent pain in the stomach, a burning sensation occurring in the throat, bruising or any other severe adverse events which have not been referenced here.

INR 0 INR 0

Availability:True

Pay mode:COD only

view details
Viraday INR   0 INR  0
-NaN%

Viraday

Viraday combines three proven anti-HIV drugs called emtricitabine, efavirenz and tenofovir disoproxil fumarate into a single pill. If taken everyday, Viraday can prevent replication and mutation of HIV-1 in adults, allowing HIV infected individuals to live long, healthy lives free from AIDS. Dosing Viraday is taken orally once a day. Gastrointestinal and nervous system side effects can be mitigated by taking Viraday on an empty stomach or right before bedtime. Patients with significant renal function impairment should avoid taking Viraday. Contraindications Contraindications include hypersensitivity to any one of Viraday's three components along with taking astemizole, cisapride, ergot derivatives, midazolam, triazolam or voriconazole. Interactions With Other Drugs Viraday may cause renal problems if taken with acyclovir, cidofovir, ganciclovir, valacyclovir or valganciclovir. Viraday can exacerbate the side effects of didanosine. Viraday's side effects can be worsened by taking atazanavir or lopinavir/ritonavir. Patients who take Viraday cannot take atazanavir without also taking ritonavir. Viraday can affect plasma concentrations of clarithromycin, rifabutin, warfarin and any medications metabolized by CYP3A4, CYP2C9 and CYP2C19. Viraday may reduce the effectiveness of methadone, possibly causing symptoms of opiate withdrawal. Patients taking Viraday with carbamazepine, phenobarbitol, or phenytoin must have their anticonvulsant levels regularly monitored. Viraday may worsen the adverse effects of psychoactive drugs on the nervous system. Viraday may inhibit the functionality of ethinyl estradiol, which plays a vital role in many contraceptives. Rifampin and anything containing hypericum perforatum, or St. John's wort, can render efavirenz ineffective, possibility resulting in the HIV becoming immune to the drug. Pregnancy & Lactation One of Viraday's key ingredients, efavirenz, poses a risk of birth defects to pregnant women. HIV infected mothers shouldn't breastfeed due to the risk of transmitting the virus to their infant. Overdose High doses of Viraday can cause long term damage to the body, so seek immediate medical care if you ingest more than the recommended amount. A haemodialysis, hemodialysis or oral charcoal may be needed to purge toxic chemicals from the body.

INR 0 INR 0

Availability:True

Pay mode:COD only

view details
Velpanat INR   0 INR  0
-NaN%

Velpanat

Velpanat medication is a combination of sofosbuvir and velpatasvir. This drug work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Sofosbuvir and Velpatasvir (Velpanat) is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin). Velpanat is a prescription drugs. This drug is available in a tablets form and is a combination of Velpatasvir 100 mg and Sofosbuvir 400 mg. This combination of two leading salt is really work wonders when it comes to the patients suffering from Hepatitis C. Patients can have this particular drug in the form of a single tablet on a daily basis. This drug is the first treatment of its kind that operates on all the genotypic 1 to 6 HCV in a successful manner. Hetero Velpanat is very helpful for the treatment of those people who are affected by the ailment of chronic Hepatitis C. This drug is sold under the brand name Velpanat and the main active ingredients in this drug are Velpatasvir and Sofosbuvir in the different quantities. Natco Pharma manufactures Velpanat in India and is sold in a bottle with the packing of 28 tablets. Velpanat medicine has been proved very effective for the patients with the chronic Hepatitis C. Being the combination of two different drugs, it has proved to be effective in the treatment of different regimes related to Hepatitis C and does the anti HCV activity in a significant manner leading to the cure of the Hepatitis C ailment.

INR 0 INR 0

Availability:True

Pay mode:COD only

view details
Velasof USD   0 USD  0
-NaN%

Velasof

Velasof medication is a combination of sofosbuvir and velpatasvir. This drug work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Sofosbuvir and Velpatasvir is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin). Velasof is a prescription drugs. This drug is available in a tablets form and is a combination of Velpatasvir 100 mg and Sofosbuvir 400 mg. This combination of two leading salt is really work wonders when it comes to the patients suffering from Hepatitis C. Patients can have this particular drug in the form of a single tablet on a daily basis. This drug is the first treatment of its kind that operates on all the genotypic 1 to 6 HCV in a successful manner. Hetero Velasof is very helpful for the treatment of those people who are affected by the ailment of chronic Hepatitis C. This drug is sold under the brand name Velasof and the chief active ingredients in this drug are Velpatasvir and Sofosbuvir in the different quantities. The manufacturing company of this medicine is Hetero Healthcare Limited in India and is sold in a bottle with the packing of 28 tablets. Velasof medicine has been proved very effective for the patients with the chronic Hepatitis C. Being the combination of two different drugs, it has proved to be effective in the treatment of different regimes related to Hepatitis C and does the anti HCV activity in a significant manner leading to the cure of the Hepatitis C ailment.

USD 0 USD 0

Availability:True

Pay mode:COD only

view details
Soranib 200 mg (Sorafenib 200 mg) - Generic Nexavar USD   0 USD  0
-NaN%

Soranib 200 mg (Sorafenib 200 mg) - Generic Nexavar

Soranib (Sorafenib) is used to treat cancer occuring in the kidneys (renal cell carcinoma) or liver (hepatocellular carcinoma). It works by inhibiting the action of the enzymes that tell the cancer cells to grow and multiply, while also stopping blood vessels from growing within the tumor, thereby preventing the cancer from growing. We are pioneer supplier of Soranib 200 mg to Russia. Soranib (Sorafenib) tablets are swallowed whole, with a full glass of water. They should be taken on an empty stomach, at least 1 to 2 hours after a meal. The exact dosage varies, depending on the condition being treated as well as the patients response to treatment. Patients should consult their physician before taking this medication in order to determine the correct dosage. You should never exceed the dose recommended to you by your physician.

USD 0 USD 0

Availability:True

Pay mode:COD only

view details
Finpecia 1 mg (Finasteride 1 mg) USD   0 USD  0
-NaN%

Finpecia 1 mg (Finasteride 1 mg)

Finpecia 1mg tablets contain finasteride 1 mg which is used to treat male pattern baldness to prevent and reverse the hair loss process. Finpecia 1mg tablets inhibit the formation of the male hormone dihydrotestosterone (DHT), which causes hair loss. You should continue to take Finpecia 1mg tablets for as long as your doctor recommends. This may be for 3 months or longer as this is how long it usually takes for new hair to grow and before increased hair growth and/or prevention of further hair loss is observed. Continued use is recommended to obtain maximum benefit, and if you stop taking your Finpecia 1mg tablets during this time, the beneficial effect of Finpecia is reversed and hair loss may resume within 12 months.

USD 0 USD 0

Availability:True

Pay mode:COD only

view details
Hepcinat - LP INR   0 INR  0
-NaN%

Hepcinat - LP

We are pioneer supplier of Hepcinat to Russia. HEPCINAT-LP contains polymerase inhibitors which called sofosbuvir and ledipasvir . Hepcinat-LP manufactured by Natco Pharma and approved for treatment of patients infected with Hepatitis C (HCV genotypes 1 and 4). Sofosbuvir & Ledipasvir is FDA-approved and EASL recommended treatment protocol for HCV, which does not include interferon or ribavirin. The clinical trials have proven very high success rate of sofosbuvir in combination with ledipasvir. Hepcinat-LP Tablets is a formulation combination of anti-viral medications Ledipasvir and Sofosbuvir used in the treatment of Chronic Hepatitis C Virus (CHCV) infection genotype 1. Hepcinat-LP is a prescription medicine containing Ledipasvir (90mg) a viral NS5A inhibitor and Sofosbuvir (400mg) a nucleotide inhibitor of the viral RNA polymerase. In one of official clinical trials involved more than 1,600 people with HCV genotype 1. The course of treatment was only 84 days. By the end of therapy 1556 patients achieved the primary target – absence of the virus. Adverse events that occurred in patients receiving sofosbuvir together with ledipasvir were mild and generally accompanied by headache and fatigue. Working pattern: Sofosbuvir+ledipasvir targetly affects to specific proteins involved in viral replication and thus totally stop the disease.

INR 0 INR 0

Availability:True

Pay mode:COD only

view details
1
false